INTERACTION OF THE ATYPICAL NEUROLEPTIC CLOZAPINE WITH 5-HT3 RECEPTORS IN THE CEREBRAL-CORTEX AND SUPERIOR CERVICAL-GANGLION OF THE RAT

被引:57
作者
WATLING, KJ [1 ]
BEER, MS [1 ]
STANTON, JA [1 ]
NEWBERRY, NR [1 ]
机构
[1] MERCK SHARP & DOHME LTD, NEUROSCI RES CTR, HARLOW CM20 2QR, ESSEX, ENGLAND
关键词
5-HT[!sub]3[!/sub] receptor sites; !sup]3[!/sup]H]Q ICS 205-930; Brain (rat); Clozapine; Neuroleptics; Superior cervical ganglion (rat);
D O I
10.1016/0014-2999(90)90043-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clozapine, an atypical neuroleptic drug devoid of extrapyramidal side effects, was a moderately potent, competitive inhibitor of the binding of [3H]quaternised ICS 205-930 to 5-HT3 receptor sites in rat cortical membranes, possessing a pKi value of 7.0. In contrast, several other antipsychotic agents, including fluphenazine, α-flupenthixol, haloperidol, spiperone and (-)-sulpiride were essentially inactive. Clozapine also antagonised the 2-methyl 5-HT-induced depolarisation of the rat isolated superior cervical ganglion, a response known to be mediated via 5-HT3 receptors. Clozapine (0.1-1 μM) induced parallel displacements to the right of the dose-response curve to 2-methyl 5-HT in this tissue, possessing a pKb value of 7.3. These data suggest that the atypical antipsychotic profile of clozapine may be related, at least, in part to its ability to interact with central 5-HT3 receptor sites. © 1990.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 42 条
[1]   EFFECT OF CLOZAPINE ON TURNOVER OF DOPAMINE IN CORPUS STRIATUM AND IN LIMBIC SYSTEM [J].
ANDEN, N ;
STOCK, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) :346-348
[2]   EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J].
ANDERSEN, PH ;
BRAESTRUP, C .
JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) :1822-1831
[3]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[4]   DIFFERENTIAL EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS ON THE SUPPRESSANT ACTION OF 2-METHYLSEROTONIN ON MEDIAL PREFRONTAL CORTICAL-CELLS - A MICROIONTOPHORETIC STUDY [J].
ASHBY, CR ;
EDWARDS, E ;
HARKINS, KL ;
WANG, RY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :583-584
[5]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551
[6]   DIFFERENTIAL EFFECT OF NEUROLEPTIC DRUGS ON DOPAMINE TURNOVER IN EXTRAPYRAMIDAL AND LIMBIC SYSTEM [J].
BARTHOLINI, G .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (05) :429-433
[7]   ACTIVATION OF A 5-HT3 RECEPTOR RELEASES DOPAMINE FROM RAT STRIATAL SLICE [J].
BLANDINA, P ;
GOLDFARB, J ;
GREEN, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :349-350
[8]  
BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P
[9]   EFFECT OF SEROTONIN ANTAGONISM IN SCHIZOPHRENIA - A PILOT-STUDY WITH SETOPERONE [J].
CEULEMANS, DLS ;
GELDERS, YG ;
HOPPENBROUWERS, MLJA ;
REYNTJENS, AJM ;
JANSSEN, PAJ .
PSYCHOPHARMACOLOGY, 1985, 85 (03) :329-332
[10]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894